Later lines in pMMR/MSS metastatic colorectal cancer: News opportunities with immunotherapy and local treatments
Colorectal cancer (CRC) is one of the most prevalent malignancies, and most patients are diagnosed with metastatic disease at first presentation. However, immunotherapy is particularly useful only in a limited number of patients with mismatch repair-deficient/high microsatellite instability metastat...
Saved in:
Main Authors: | Alfredo Colombo (Author), Concetta Maria Porretto (Author) |
---|---|
Format: | Book |
Published: |
Society of Gastrointestinal Intervention,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: literature review and a case report
by: A. D. Darenskaya, et al.
Published: (2024) -
Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2024) -
How to treat liver metastases in colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2024) -
Anti-vascular endothelial growth factor receptor in colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2023) -
Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018)